110 related articles for article (PubMed ID: 17582546)
21. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
[TBL] [Abstract][Full Text] [Related]
22. Methylphenidate: Gender trends in adult and pediatric populations over a 7year period.
Ehrhardt C; Boucherie Q; Pauly V; Braunstein D; Ronflé E; Thirion X; Frauger E; Micallef J
Therapie; 2017 Dec; 72(6):635-641. PubMed ID: 29061293
[TBL] [Abstract][Full Text] [Related]
23. [Use of methylphenidate among children in Iceland 1989-2006].
Zoëga H; Baldursson G; Halldórsson M
Laeknabladid; 2007 Dec; 93(12):825-32. PubMed ID: 18057472
[TBL] [Abstract][Full Text] [Related]
24. Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder?
Walitza S; Werner B; Romanos M; Warnke A; Gerlach M; Stopper H
Environ Health Perspect; 2007 Jun; 115(6):936-40. PubMed ID: 17589603
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study.
Wigal SB; Nordbrock E; Adjei AL; Childress A; Kupper RJ; Greenhill L
CNS Drugs; 2015 Apr; 29(4):331-40. PubMed ID: 25877989
[TBL] [Abstract][Full Text] [Related]
26. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.
Walitza S; Kämpf K; Artamonov N; Romanos M; Gnana Oli R; Wirth S; Warnke A; Gerlach M; Stopper H
Toxicol Lett; 2009 Jan; 184(1):38-43. PubMed ID: 19015014
[TBL] [Abstract][Full Text] [Related]
27. Methylphenidate: prescribing patterns in a South African primary care patient population.
Truter I
J Clin Pharm Ther; 2005 Feb; 30(1):59-63. PubMed ID: 15659004
[TBL] [Abstract][Full Text] [Related]
28. Trends in incidence and characteristics of children, adolescents, and adults initiating immediate- or extended-release methylphenidate or atomoxetine in the Netherlands during 2001-2006.
van den Ban E; Souverein P; Swaab H; van Engeland H; Heerdink R; Egberts T
J Child Adolesc Psychopharmacol; 2010 Feb; 20(1):55-61. PubMed ID: 20166797
[TBL] [Abstract][Full Text] [Related]
29. Absence of cytogenetic effects in children and adults with attention-deficit/hyperactivity disorder treated with methylphenidate.
Ponsa I; Ramos-Quiroga JA; Ribasés M; Bosch R; Bielsa A; Ordeig MT; Morell M; Miró R; de Cid R; Estivill X; Casas M; Bayés M; Cormand B; Hervás A
Mutat Res; 2009 Jun; 666(1-2):44-9. PubMed ID: 19457516
[TBL] [Abstract][Full Text] [Related]
30. Prescriptions for ADHD medication, 2004-08.
Lillemoen PK; Kjosavik SR; Hunskår S; Ruths S
Tidsskr Nor Laegeforen; 2012 Sep; 132(16):1856-60. PubMed ID: 22986969
[TBL] [Abstract][Full Text] [Related]
31. The use of methylphenidate in Michigan.
Rappley MD; Gardiner JC; Jetton JR; Houang RT
Arch Pediatr Adolesc Med; 1995 Jun; 149(6):675-9. PubMed ID: 7767425
[TBL] [Abstract][Full Text] [Related]
32. Effect of transitioning from extended-release methylphenidate onto osmotic, controlled-release methylphenidate in children/adolescents with ADHD: results of a 3-month non-interventional study.
Wolff C; Alfred A; Lindermüller A; Rettig K; Mattejat F; Gerwe M; Slawik L; Schäuble B
Curr Med Res Opin; 2011; 27 Suppl 2():35-44. PubMed ID: 21787126
[TBL] [Abstract][Full Text] [Related]
33. Identifying patient subgroups who benefit most from a treatment: using administrative claims data to uncover treatment heterogeneity.
Erder MH; Signorovitch JE; Setyawan J; Yang H; Parikh K; Betts KA; Xie J; Hodgkins P; Wu EQ
J Med Econ; 2012; 15(6):1078-87. PubMed ID: 22537226
[TBL] [Abstract][Full Text] [Related]
34. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
[TBL] [Abstract][Full Text] [Related]
35. [Variability and tendencies in the consumption of methylphenidate in Spain. An estimation of the prevalence of attention deficit hyperactivity disorder].
Criado Alvarez JJ; Romo Barrientos C
Rev Neurol; 2003 Nov 1-15; 37(9):806-10. PubMed ID: 14606045
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of dexamphetamine and methylphenidate for the treatment of childhood attention deficit hyperactivity disorder.
Donnelly M; Haby MM; Carter R; Andrews G; Vos T
Aust N Z J Psychiatry; 2004 Aug; 38(8):592-601. PubMed ID: 15298581
[TBL] [Abstract][Full Text] [Related]
37. Effects of late-afternoon methylphenidate administration on behavior and sleep in attention-deficit hyperactivity disorder.
Kent JD; Blader JC; Koplewicz HS; Abikoff H; Foley CA
Pediatrics; 1995 Aug; 96(2 Pt 1):320-5. PubMed ID: 7630692
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of methylphenidate prescription among school-aged children in a Swiss population: increase in the number of prescriptions in the Swiss Canton of Vaud, from 2002 to 2005, and changes in patient demographics.
Gumy C; Huissoud T; Dubois-Arber F
J Atten Disord; 2010 Nov; 14(3):267-72. PubMed ID: 20484708
[TBL] [Abstract][Full Text] [Related]
39. [Hyperactivity and prescription of Ritalin in the canton of Vaud (Switzerland), 2002].
Huissoud T; Jeannin A; Dubois-Arber F
Rev Epidemiol Sante Publique; 2007 Oct; 55(5):357-63. PubMed ID: 17889474
[TBL] [Abstract][Full Text] [Related]
40. Prospective, naturalistic study of open-label OROS methylphenidate treatment in Chinese school-aged children with attention-deficit/hyperactivity disorder.
Zheng Y; Wang YF; Qin J; Wang LW; Zou LP; Jin XM; Xu T; Wang Y; Qi YL; Gong ME; Yin QY; Mai JN; Jing J; Luo XY; Ma HW; Li HB; Xie L; Li Y; Kuang GF; Yi MJ; Wang F; Zhu XH; Yao YB
Chin Med J (Engl); 2011 Oct; 124(20):3269-74. PubMed ID: 22088519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
